- Home
- BKKT vs CTOR Comparison
BKKT vs CTOR Comparison
Compare BKKT & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKKT
- CTOR
- Stock Information
- Founded
- BKKT 2018
- CTOR 2021
- Country
- BKKT United States
- CTOR United States
- Employees
- BKKT N/A
- CTOR N/A
- Industry
- BKKT Computer Software: Prepackaged Software
- CTOR
- Sector
- BKKT Technology
- CTOR
- Exchange
- BKKT Nasdaq
- CTOR NYSE
- Market Cap
- BKKT 87.4M
- CTOR 89.9M
- IPO Year
- BKKT N/A
- CTOR N/A
- Fundamental
- Price
- BKKT $11.18
- CTOR $0.75
- Analyst Decision
- BKKT Hold
- CTOR Strong Buy
- Analyst Count
- BKKT 2
- CTOR 2
- Target Price
- BKKT $13.13
- CTOR $4.50
- AVG Volume (30 Days)
- BKKT 358.2K
- CTOR 47.9K
- Earning Date
- BKKT 03-17-2025
- CTOR 02-14-2025
- Dividend Yield
- BKKT N/A
- CTOR N/A
- EPS Growth
- BKKT N/A
- CTOR N/A
- EPS
- BKKT N/A
- CTOR N/A
- Revenue
- BKKT $1,907,413,000.00
- CTOR N/A
- Revenue This Year
- BKKT N/A
- CTOR N/A
- Revenue Next Year
- BKKT $11.81
- CTOR N/A
- P/E Ratio
- BKKT N/A
- CTOR N/A
- Revenue Growth
- BKKT 228.00
- CTOR N/A
- 52 Week Low
- BKKT $5.57
- CTOR $0.69
- 52 Week High
- BKKT $37.21
- CTOR $49.00
- Technical
- Relative Strength Index (RSI)
- BKKT 35.38
- CTOR N/A
- Support Level
- BKKT $12.04
- CTOR N/A
- Resistance Level
- BKKT $16.80
- CTOR N/A
- Average True Range (ATR)
- BKKT 1.62
- CTOR 0.00
- MACD
- BKKT 0.25
- CTOR 0.00
- Stochastic Oscillator
- BKKT 6.33
- CTOR 0.00
About BKKT Bakkt Holdings Inc.
Bakkt Holdings Inc operates technology that connects the digital economy by offering a platform for crypto and redeeming loyalty points. Its institutional-grade technology platform provides a custody solution that caters to more experienced market participants to store crypto and provides consumers, businesses, and institutions with the ability to buy, sell, and store crypto in a simple, intuitive digital experience accessed via application programming interfaces (APIs) or embedded web experience, and Loyalty offers a full spectrum of content that clients can make available to its customers when redeeming loyalty currencies. It generates revenue in the form of Subscription and service and Transaction revenue.
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.